Published in Ann Rheum Dis on March 01, 1986
Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet's disease. Clin Exp Immunol (1990) 1.05
CD4 and CD8 cell responses to herpes simplex virus in Behçet's disease. Clin Exp Immunol (1988) 0.98
Microarray analysis of mercury-induced changes in gene expression in human liver carcinoma (HepG2) cells: importance in immune responses. Int J Environ Res Public Health (2006) 0.78
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Behçet's syndrome with arthritis. Ann Rheum Dis (1969) 5.99
Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells. Nature (1977) 1.88
Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis. Arthritis Rheum (1982) 1.73
Assay of an interferon-induced enzyme in white blood cells as a diagnostic aid in viral diseases. Lancet (1981) 1.59
Synthesis of 2'5'-oligo(A) in extracts of interferon-treated HeLa cells. J Biol Chem (1979) 1.49
Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis. Clin Exp Immunol (1982) 1.14
Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome. Clin Exp Immunol (1984) 1.01
Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases. Ann Rheum Dis (1982) 0.97
Enzyme markers for the presence of circulating interferon: 2-5A synthetase in blood lymphocytes and protein kinase in platelet-rich plasma. Proc Soc Exp Biol Med (1984) 0.96
Clinical value of the determination of an interferon-induced enzyme activity: studies of the 2'5' oligoadenylate synthetase activity in peripheral blood lymphocytes of patients. Biomed Pharmacother (1983) 0.86
Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98
Systemic lupus erythematosus syndrome induced by practolol. Br Med J (1973) 6.59
The lymphocyte transformation test and gold hypersensitivity. Ann Rheum Dis (1968) 3.54
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42
Accidental hypothermia and impaired temperature homoeostasis in the elderly. Br Med J (1977) 2.42
Changes in the life-span of circulating small lymphocytes in mice after treatment with anti-lymphocyte globulin. Lancet (1968) 2.21
Emergency contraception. BMJ (1995) 2.04
Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice. Immunology (1968) 1.98
Neurological complications in Behçet's syndrome. Brain (1999) 1.68
Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61
Suppression of Coombs-positive haemolytic anaemia in NZB mice by antilymphocyte globulin. Lancet (1967) 1.57
Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J Clin Invest (1978) 1.55
Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53
Mode of action of anti-lymphocyte globulin. II. Changes in the lymphoid cell population in rats treated with anti-lymphocyte globulin. Immunology (1968) 1.49
Virus infections of lympho-reticular cells and auto-immune diseases. Transplant Rev (1976) 1.45
Depletion of long-lived lymphocytes in old New Zealand black mice. Clin Exp Immunol (1970) 1.44
Susceptibility of human lymphocyte populations to infection by herpes simplex virus. Immunology (1977) 1.37
Inactivation of myxoviruses by lymphoid cells. J Gen Virol (1973) 1.33
Control mechanisms in infectious mononucleosis. Clin Exp Immunol (1974) 1.29
Effect of anti-lymphocyte globulin on kidney disease in (N.Z.B. x N.Z.W.) F 1 mice. Lancet (1966) 1.27
Effect of aging on the prognostic significance of ambulatory systolic, diastolic, and pulse pressure in essential hypertension. Circulation (2001) 1.26
The selective release of lysosomal acid hydrolases from mouse peritoneal macrophages by stimuli of chronic inflammation. Br J Exp Pathol (1977) 1.22
Lymphocyte abnormalities in Behçet's syndrome. Clin Exp Immunol (1980) 1.20
The Guillain-Barré syndrome following Campylobacter enteritis with recovery after plasmapheresis. J Infect (1983) 1.18
A new manifestation of infection with Epstein-Barr virus. Br Med J (1978) 1.14
Epidemiology of gonococcal and chlamydial infections in Harrow and Brent. Genitourin Med (1996) 1.14
Defective B cell function in systemic lupus erythematosus. Clin Exp Immunol (1982) 1.13
Improvement of Bacillus sphaericus toxicity against dipteran larvae by integration, via homologous recombination, of the Cry11A toxin gene from Bacillus thuringiensis subsp. israelensis. Appl Environ Microbiol (1997) 1.13
Left ventricular function during isometric hand grip and cold stress in normal subjects. Br Heart J (1986) 1.11
Thrombosis in Behçet's disease: a retrospective survey from a single UK centre. Rheumatology (Oxford) (2001) 1.11
Subjective characteristics of sleep in the elderly. Age Ageing (1978) 1.11
Prediction of coronary and cerebrovascular morbidity and mortality by direct continuous ambulatory blood pressure monitoring in essential hypertension. Circulation (1999) 1.09
Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains. Clin Exp Immunol (1969) 1.08
Studies of the effect of induced immune lymphopenia. I. Enhanced effects of rabbit anti-rat lymphocyte globulin in rats tolerant to rabbit immunoglobulin G. J Immunol (1967) 1.08
Lysosomal enzyme secretion by macrophages during intracellular storage of particles. Biochim Biophys Acta (1979) 1.07
Infection and interferon production in systemic juvenile chronic arthritis: a prospective study. Ann Rheum Dis (1984) 1.07
Lymphokine-activated killer cell activity in rheumatoid arthritis. Clin Exp Immunol (1987) 1.05
Inactivation of influenza virus by human lymphocytes. Clin Exp Immunol (1974) 1.04
Herpes simplex virus depresses antibody production by affecting T-cell function. Nature (1980) 1.04
Influence of dendritic cells on tumor growth. Proc Natl Acad Sci U S A (1985) 1.02
Chlorambucil-induced chromosome damage to human lymphocytes is dose-dependent and cumulative. Lancet (1984) 1.02
Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome. Clin Exp Immunol (1984) 1.01
Termination of acquired tolerance by administration of small lymphocytes. J Immunol (1967) 1.01
Radiosensitivity of peripheral blood lymphocytes in autoimmune disease. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 1.01
Fate of herpes simplex virus in lymphocytes from inflammatory joint effusions. i. Failure of the virus to grow in cultured lymphocytes. Ann Rheum Dis (1979) 1.01
Induction of lysosomal enzyme release from cultured macrophages by dextran sulfate. Clin Immunol Immunopathol (1977) 0.99
Replication or inactivation of different viruses by human lymphocyte preparations. Infect Immun (1974) 0.99
Self-tolerance and autoimmunity. Br Med Bull (1976) 0.97
Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases. Ann Rheum Dis (1982) 0.97
Cyclosporin A in the treatment of severe Behçet's uveitis. Br J Rheumatol (1987) 0.97
Defective repair of 0(6)-methylguanine in autoimmune diseases. Lancet (1982) 0.96
Immunodeficiency and general medicine. Br Med J (1980) 0.95
Pregnancy and immunological disorders. Br Med J (Clin Res Ed) (1982) 0.94
Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studies. Clin Exp Immunol (1983) 0.93
Measruement of immunological function in man: interaction between virus and human leukocytes. Proc R Soc Med (1974) 0.93
Fate of herpes simplex virus in lymphocytes from inflammatory joint effusions. ii. Mechanisms of non-permissiveness. Ann Rheum Dis (1979) 0.93
The viral theory of connective tissue diseases: a review. Med Biol (1975) 0.93
The rheumatoid synovial membrane participates in systemic anti-viral immune responses. Clin Exp Immunol (1985) 0.93
A search for retrovirus infection in systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis (1988) 0.90
Review: method of separating human blood lymphoid cell populations. J Immunol Methods (1973) 0.89
Normal induction and maintenance of tolerance in (NZBxNZW) F1 mice. Clin Exp Immunol (1969) 0.89
Improved graft survival after treatment with Bordetella and anti-lymphocyte serum. Nature (1969) 0.88
Autoimmune disease in inbred mice. Clin Exp Immunol (1967) 0.88
Induction of macrophage lysosomal enzyme secretion by agents acting at the plasma membrane. Exp Cell Biol (1979) 0.88
Spontaneous production of B cell growth factors by SLE lymphocytes. Clin Exp Immunol (1987) 0.87
Thermoregulation in burn patients during exercise. J Burn Care Rehabil (2003) 0.87
Intensive immunosuppression in intractable rheumatoid arthritis. Br J Rheumatol (1986) 0.87
The treatment of connective tissue diseases with antilymphocyte globulin. Postgrad Med J (1976) 0.86
Nature and diagnosis of food allergy. Proc Nutr Soc (1979) 0.86
Cytokine-independent progression of immunoglobulin production in vitro by B lymphocytes from patients with systemic lupus erythematosus. Clin Exp Immunol (1991) 0.86
Malignancies induced by chlorambucil. Cancer Treat Rev (1984) 0.85
Activation of IL-6 production by UV irradiation of blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol (1992) 0.85
Selective immunosuppressive effects of measles virus infection. Clin Exp Immunol (1982) 0.85
Lymphocyte function and virus infections. J Clin Pathol Suppl (R Coll Pathol) (1979) 0.85
Immunopathology of New Zealand Black mice treated with antilymphocyte globulin. Immunology (1971) 0.84
Treatment with acyclovir does not affect orogenital ulcers in Behçet's syndrome: a randomized double-blind trial. Br J Rheumatol (1988) 0.84
Renal disease in (NZB x NZW)F1 hybrid mice treated with anti-lymphocytic antibody. Clin Exp Immunol (1970) 0.83
Increased sensitivity of lymphocytes from patients with systemic autoimmune diseases to DNA alkylation by the methylating carcinogen N-methyl-N-nitrosourea. Ann Rheum Dis (1988) 0.83
Immunoregulatory effects of interferon-alpha. I. Interferon-alpha inhibits in vitro antibody synthesis by normal human lymphocytes. Clin Exp Immunol (1985) 0.82
Endothelial prostacyclin release in systemic lupus erythematosus. Thromb Haemost (1989) 0.82
Immunity and depression. Br Med J (Clin Res Ed) (1986) 0.82
Induction of antibody synthesis in cultures of human lymphoid cells. Int Arch Allergy Appl Immunol (1973) 0.81
Retroperitoneal fibrosis and polyarteritis nodosa successfully treated by intensive immunosuppression. J R Soc Med (1980) 0.81
Development and field performance of a broad-spectrum nonviable asporogenic recombinant strain of Bacillus thuringiensis with greater potency and UV resistance. Appl Environ Microbiol (1999) 0.81
Lymphocyte responses in juvenile chronic arthritis and Behçet's disease--cell number requirements and effects of glucocorticosteroid therapy. Clin Exp Immunol (1982) 0.80
Inflammatory disorders of muscle. Aetiology. Clin Rheum Dis (1984) 0.80
Rheumatoid arthritis--a virus disease? J Clin Pathol Suppl (R Coll Pathol) (1978) 0.79
Scleroderma treated with immunosuppressive drugs. Br J Dermatol (1979) 0.79
Rheumatoid arthritis. Aetiology. Br Med J (1970) 0.79
Rheumatoid arthritis in a patient with primary hypogammaglobulinaemia. Br J Rheumatol (1993) 0.79
Herpes simplex virus and the rheumatic diseases. Rheumatol Int (1989) 0.78
A comprehensive clinical validation of the nuclear stethoscope. Nucl Med Commun (1986) 0.78
Cardiac output and the recumbent position in late pregnancy. Anaesthesia (1983) 0.78